A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Accupril Patient, Information, Instructions - Quinapril Hcl
Accupril Patient, Information, Instructions - Quinapril Hcl
PATIENT INFORMATION
Pregnancy
Female patients of childbearing age should be told about the
consequences of second- and third-trimester exposure to ACE inhibitors, and
they should also be told that these consequences do not appear to have resulted
from intrauterine ACE-inhibitor exposure that has been limited to the first
trimester. These patients should be asked to report pregnancies to their physicians
as soon as possible.
Angioedema
Angioedema, including laryngeal edema can occur with treatment
with ACE inhibitors, especially following the first dose. Patients should be
so advised and told to report immediately any signs or symptoms suggesting angioedema
(swelling of face, extremities, eyes, lips, tongue, difficulty in swallowing
or breathing) and to stop taking the drug until they have consulted with their
physician (see WARNINGS).
Symptomatic hypotension
Patients should be cautioned that lightheadedness can occur,
especially during the first few days of ACCUPRIL therapy, and that it should
be reported to a physician. If actual syncope occurs, patients should be told
to not take the drug until they have consulted with their physician (see WARNINGS).
All patients should be cautioned that inadequate fluid intake
or excessive perspiration, diarrhea, or vomiting can lead to an excessive fall
in blood pressure because of reduction in fluid volume, with the same consequences
of lightheadedness and possible syncope.
Patients planning to undergo any surgery and/or anesthesia
should be told to inform their physician that they are taking an ACE inhibitor.
Hyperkalemia
Patients should be told not to use potassium supplements or
salt substitutes containing potassium without consulting their physician (see
PRECAUTIONS).
Neutropenia
Patients should be told to report promptly any indication of
infection (eg, sore throat, fever) which could be a sign of neutropenia.
NOTE: As with many other drugs, certain advice to patients
being treated with ACCUPRIL is warranted. This information is intended to aid
in the safe and effective use of this medication. It is not a disclosure of
all possible adverse or intended effects.
top
